Following a public consultation, NICE has revised its draft recommendation on a treatment for Dupuytren’s contracture – the condition where fingers gradually bend in towards the palm of the hand and cannot be straightened. 

The NICE independent Appraisal Committee examined the clinical and cost effectiveness of using collagenase clostridium histolyticum (Xiapex) for treating Dupuytren’s contracture in adults.  The first draft guidance proposed to not recommend collagenase clostridium histolyticum (CCH) for this use. Following the public consultation on the draft recommendation, the committee has taken into account the consultation responses received.  As a result, in the final draftguidance the committee now recommends further research rather than routine use.

For more details, go to: https://www.nice.org.uk/news/press-and-media/nice-proposes-research-recommendation-for-dupuytren’s-disease-finger-contracture-treatment